Psoriasis in the patient with human immunodeficiency virus, Part 2: Review of treatment.
Psoriasis is a chronic, immune-mediated skin disease affecting approximately 1% to 3% of the human immunodeficiency virus (HIV)-infected population. Psoriasis appears in patients with HIV either as the first clinical manifestation of the disease or, less commonly, during the advanced stages of HIV when it has progressed to AIDS. This 2-part series reviews the pathogenesis of HIV-associated psoriasis as well as the various therapeutic regimens that have effectively treated psoriasis in patients with HIV. These therapies address the profound immune dysregulation that defines psoriasis. The second part of the series focuses on the treatment of HIV-associated psoriasis.
University of Miami School of Medicine, Florida, USA.
Rita V
RV
Patel
Jeffrey M
JM
Weinberg
D015658:HIV Infections / Q000150:complications / Q000276:immunology*; D006801:Humans; D016867:Immunocompromised Host; D011565:Psoriasis / Q000209:etiology / Q000276:immunology* / Q000628:therapy*